U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Aplasia/Hypoplasia involving the central nervous system

MedGen UID:
871188
Concept ID:
C4025665
Finding
Synonyms: Absent/underdeveloped central nervous system tissue; Aplasia/Hypoplasia involving the CNS
 
HPO: HP:0002977

Definition

Absence or underdevelopment of tissue in the central nervous system. [from HPO]

Conditions with this feature

Child syndrome
MedGen UID:
82697
Concept ID:
C0265267
Disease or Syndrome
The NSDHL-related disorders include: CHILD (congenital hemidysplasia with ichthyosiform nevus and limb defects) syndrome, an X-linked condition that is usually male lethal during gestation and thus predominantly affects females; and CK syndrome, an X-linked disorder that affects males. CHILD syndrome is characterized by unilateral distribution of ichthyosiform (yellow scaly) skin lesions and ipsilateral limb defects that range from shortening of the metacarpals and phalanges to absence of the entire limb. Intellect is usually normal. The ichthyosiform skin lesions are usually present at birth or in the first weeks of life; new lesions can develop in later life. Nail changes are also common. The heart, lung, and kidneys can also be involved. CK syndrome (named for the initials of the original proband) is characterized by mild to severe cognitive impairment and behavior problems (aggression, attention deficit hyperactivity disorder, and irritability). All affected males reported have developed seizures in infancy and have cerebral cortical malformations and microcephaly. All have distinctive facial features, a thin habitus, and relatively long, thin fingers and toes. Some have scoliosis and kyphosis. Strabismus is common. Optic atrophy is also reported.
Xeroderma pigmentosum, group F
MedGen UID:
120612
Concept ID:
C0268140
Congenital Abnormality
Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).
Angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert
MedGen UID:
347234
Concept ID:
C1859783
Disease or Syndrome
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome
MedGen UID:
482486
Concept ID:
C3280856
Disease or Syndrome
ISQMR is a severe autosomal recessive disorder characterized by ichthyosis apparent from birth, profound psychomotor retardation with essentially no development, spastic quadriplegia, and seizures (summary by Aldahmesh et al., 2011).
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
MedGen UID:
873604
Concept ID:
C4040739
Disease or Syndrome
The phenotypic spectrum of SERAC1 deficiency comprises MEGD(H)EL syndrome (3-methylglutaconic aciduria with deafness-dystonia, [hepatopathy], encephalopathy, and Leigh-like syndrome), juvenile-onset complicated hereditary spastic paraplegia (in 1 consanguineous family), and adult-onset generalized dystonia (in 1 adult male). MEGD(H)EL syndrome is characterized in neonates by hypoglycemia and a sepsis-like clinical picture for which no infectious agent can be found. During the first year of life feeding problems, failure to thrive, and/or truncal hypotonia become evident; many infants experience (transient) liver involvement ranging from undulating transaminases to prolonged hyperbilirubinemia and near-fatal liver failure. By age two years progressive deafness, dystonia, and spasticity prevent further psychomotor development and/or result in loss of acquired skills. Affected children are completely dependent on care for all activities of daily living; speech is absent.

Recent clinical studies

Etiology

Gilles A, Song JJ, Hofkens-Van den Brandt A, Mertens G, Matthies C, Staelens S, Stroobants S, Vanderveken O, Topsakal V, Van de Heyning P, Van Rompaey V
Otol Neurotol 2020 Jan;41(1):e15-e20. doi: 10.1097/MAO.0000000000002474. PMID: 31821261
Deal C, Hasselmann C, Pfäffle RW, Zimmermann AG, Quigley CA, Child CJ, Shavrikova EP, Cutler GB Jr, Blum WF
Horm Res Paediatr 2013;79(5):283-92. Epub 2013 May 16 doi: 10.1159/000350829. PMID: 23689058
Siegel DH, Tefft KA, Kelly T, Johnson C, Metry D, Burrows P, Pope E, Cordisco M, Holland KE, Maheshwari M, Keith P, Garzon M, Hess C, Frieden IJ, Fullerton HJ, Drolet BA
Stroke 2012 Jun;43(6):1672-4. Epub 2012 Mar 22 doi: 10.1161/STROKEAHA.112.650952. PMID: 22442177
De Bellis A, Sinisi AA, Conte M, Coronella C, Bellastella G, Esposito D, Pasquali D, Ruocco G, Bizzarro A, Bellastella A
J Clin Endocrinol Metab 2007 Feb;92(2):604-7. Epub 2006 Nov 7 doi: 10.1210/jc.2006-1216. PMID: 17090639

Therapy

Gilles A, Song JJ, Hofkens-Van den Brandt A, Mertens G, Matthies C, Staelens S, Stroobants S, Vanderveken O, Topsakal V, Van de Heyning P, Van Rompaey V
Otol Neurotol 2020 Jan;41(1):e15-e20. doi: 10.1097/MAO.0000000000002474. PMID: 31821261
Deal C, Hasselmann C, Pfäffle RW, Zimmermann AG, Quigley CA, Child CJ, Shavrikova EP, Cutler GB Jr, Blum WF
Horm Res Paediatr 2013;79(5):283-92. Epub 2013 May 16 doi: 10.1159/000350829. PMID: 23689058
Siegel DH, Tefft KA, Kelly T, Johnson C, Metry D, Burrows P, Pope E, Cordisco M, Holland KE, Maheshwari M, Keith P, Garzon M, Hess C, Frieden IJ, Fullerton HJ, Drolet BA
Stroke 2012 Jun;43(6):1672-4. Epub 2012 Mar 22 doi: 10.1161/STROKEAHA.112.650952. PMID: 22442177

Prognosis

Gilles A, Song JJ, Hofkens-Van den Brandt A, Mertens G, Matthies C, Staelens S, Stroobants S, Vanderveken O, Topsakal V, Van de Heyning P, Van Rompaey V
Otol Neurotol 2020 Jan;41(1):e15-e20. doi: 10.1097/MAO.0000000000002474. PMID: 31821261

Clinical prediction guides

Gilles A, Song JJ, Hofkens-Van den Brandt A, Mertens G, Matthies C, Staelens S, Stroobants S, Vanderveken O, Topsakal V, Van de Heyning P, Van Rompaey V
Otol Neurotol 2020 Jan;41(1):e15-e20. doi: 10.1097/MAO.0000000000002474. PMID: 31821261
Deal C, Hasselmann C, Pfäffle RW, Zimmermann AG, Quigley CA, Child CJ, Shavrikova EP, Cutler GB Jr, Blum WF
Horm Res Paediatr 2013;79(5):283-92. Epub 2013 May 16 doi: 10.1159/000350829. PMID: 23689058

Recent systematic reviews

Siegel DH, Tefft KA, Kelly T, Johnson C, Metry D, Burrows P, Pope E, Cordisco M, Holland KE, Maheshwari M, Keith P, Garzon M, Hess C, Frieden IJ, Fullerton HJ, Drolet BA
Stroke 2012 Jun;43(6):1672-4. Epub 2012 Mar 22 doi: 10.1161/STROKEAHA.112.650952. PMID: 22442177

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...